Amphastar Director Richard Prins Sells Nearly 8,000 Shares Amid Market‑Aligned Pricing – Is It a Bearish Signal?
Amphastar insider sale: Richard Prins sells 7,973 shares at $20.30, sparking questions on the company’s near‑term outlook and pipeline progress.
- AMPHASTAR PHARMACEUTICALS IN
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- AI generated
3 minutes to read